888 filings
Page 4 of 45
SC 13G
ABUS
Arbutus Biopharma Corp
3 Feb 23
Arbutus Biopharma / BlackRock ownership change
12:10pm
8-K
ABUS
Arbutus Biopharma Corp
27 Jan 23
Arbutus Announces Resignation of Board Member
7:31am
8-K
ABUS
Arbutus Biopharma Corp
5 Jan 23
Arbutus Announces 2023 Corporate Objectives and Provides Financial Update
7:31am
8-K
ABUS
Arbutus Biopharma Corp
13 Dec 22
Initial data from IFN phase expected in the first half of 2023
7:31am
10-Q
2022 Q3
ABUS
Arbutus Biopharma Corp
Quarterly report
9 Nov 22
4:10pm
8-K
ABUS
Arbutus Biopharma Corp
9 Nov 22
Arbutus Reports Third Quarter 2022 Financial Results and Provides Corporate Update
7:31am
8-K
ABUS
Arbutus Biopharma Corp
4 Nov 22
Other Events
9:00am
8-K
ABUS
Arbutus Biopharma Corp
1 Nov 22
Other Events
4:02pm
8-K
ABUS
Arbutus Biopharma Corp
31 Oct 22
Arbutus Announces Three Poster Presentations with Clinical Data from AB-729 and Preclinical Data from AB-101 at AASLD - The Liver Meeting® 2022
4:19pm
8-K
ABUS
Arbutus Biopharma Corp
24 Oct 22
Departure of Directors or Certain Officers
7:01am
8-K
ABUS
Arbutus Biopharma Corp
30 Sep 22
Gaston Picchio, PhD, Chief Development Officer, to Depart Arbutus at Year End
9:02am
8-K
ABUS
Arbutus Biopharma Corp
30 Aug 22
Arbutus Biopharma Announces Issuance of a New Key U.S. Patent Related to AB-729
7:32am
S-8
ABUS
Arbutus Biopharma Corp
4 Aug 22
Registration of securities for employees
4:21pm
10-Q
2022 Q2
ABUS
Arbutus Biopharma Corp
Quarterly report
4 Aug 22
4:08pm
8-K
ABUS
Arbutus Biopharma Corp
4 Aug 22
Arbutus Reports Second Quarter 2022 Financial Results and Provides Corporate Update
7:32am
8-K
ABUS
Arbutus Biopharma Corp
20 Jul 22
Arbutus Biopharma Provides Update on the Phase 2A Combination Trial with AB-729 and a Capsid Inhibitor
4:12pm
8-K
ABUS
Arbutus Biopharma Corp
27 Jun 22
Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical Update
9:00am
8-K
ABUS
Arbutus Biopharma Corp
8 Jun 22
Arbutus to Present Seven Scientific Posters at EASL International Liver Congress™ 2022
6:00am
8-K
ABUS
Arbutus Biopharma Corp
6 Jun 22
Arbutus and Vaccitech Dose First Patient in Phase 2a Clinical Trial Combining Therapies for the Treatment of Chronic Hepatitis B Virus
7:31am
8-K
ABUS
Arbutus Biopharma Corp
31 May 22
Departure of Directors or Certain Officers
4:05pm